Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
CAI — Caris Life Sciences, Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2025 Earnings Call Summary

FEB 27, 2026
REVENUE
$292.9M +35.1%
NET MARGIN
28.0% +16.8 PTS
EPS
$0.29 +237.2%
FREE CASH FLOW
$39.7M -28.3%

No summary has been written for this call yet.